Outpatient Therapies Physicians Special Programs Patient Conditions Rehabilitation Orthopaedics

 
 

Kernan Hospital

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Ask Our Experts

Get answers to your specific medical questions from Kernan Hospital experts.

Note: This is for informational purposes only. Doctors cannot provide a diagnosis via e-mail.

 

Related Content

Kernan Hospital

Our Services

Patient Success Stories

Our Doctors

Drug-induced immune hemolytic anemia - Overview

Alternative Names

Immune hemolytic anemia secondary to drugs; Anemia - immune hemolytic - secondary to drugs

Definition of Drug-induced immune hemolytic anemia:

Drug-induced immune hemolytic anemia is a blood disorder that occurs when a medicine tells the body's defensive (immune) system to attack red blood cells. It causes red blood cells to break down earlier than normal.

See also: Hemolytic anemia

Causes, incidence, and risk factors:

Drug-induced immune hemolytic anemia occurs when a drug causes your body's immune system to react against red blood cells. In some cases, a drug can cause the immune system to mistakenly think the red blood cells are dangerous, foreign substances. Antibodies form against the red blood cells. The antibodies attach to red blood cells and cause them to break down too early.

Drugs that can cause this type of hemolytic anemia include:

  • Cephalosporins
  • Levodopa
  • Methyldopa
  • Penicillin and its derivatives
  • Quinidine
  • Some anti-inflammatory drugs

There are many other rarer causes of drug-induced hemolytic anemia. Drug-induced hemolytic anemia is associated with G6PD deficiency. But in this case, the breakdown of red blood cells is due to a certain type of stress in the cell, not the body's immune system.

Drug-induced hemolytic anemia is rare in children.

  • Reviewed last on: 4/1/2007
  • Mark Levin, MD, Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network.

References

Vandendries ER. Drug-associated disease: hematologic dysfunction. Crit Care Clin. April 2006; 22(2): 347-55, viii.

Dhaliwal G. Hemolytic anemia. Am Fam Physician. June 2004; 69(11): 2599-606.

Kasper D, Braunwald E, Fauci A, et al. Harrison's Principals of Internal Medicine. 16th edition [online version]. New York, NY: McGraw Hill; 2005.

Physicians Special Programs Patient Conditions Physical Therapy